Clorox’s (CLX) Hold Rating Reiterated at Jefferies Group
Jefferies Group restated their hold rating on shares of Clorox (NYSE:CLX) in a research report report published on Wednesday morning. Jefferies Group currently has a $130.00 target price on the stock.
Several other research analysts have also recently issued reports on the stock. Wells Fargo & Company restated a hold rating and issued a $130.00 target price on shares of Clorox in a report on Wednesday. Deutsche Bank assumed coverage on shares of Clorox in a report on Wednesday. They issued a hold rating and a $142.00 target price on the stock. Consumer Edge upgraded shares of Clorox from a neutral rating to an outperform rating in a report on Friday, November 10th. Zacks Investment Research upgraded shares of Clorox from a sell rating to a hold rating in a report on Monday, November 6th. Finally, Morgan Stanley cut their target price on shares of Clorox from $138.00 to $128.00 and set an equal weight rating on the stock in a report on Thursday, November 2nd. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company’s stock. The stock presently has an average rating of Hold and an average target price of $129.05.
Clorox (NYSE CLX) opened at $147.63 on Wednesday. The company has a quick ratio of 0.77, a current ratio of 1.10 and a debt-to-equity ratio of 3.02. Clorox has a fifty-two week low of $117.94 and a fifty-two week high of $148.23. The stock has a market cap of $18,858.56, a P/E ratio of 26.35, a PEG ratio of 3.98 and a beta of 0.43.
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Wednesday, January 24th will be paid a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a yield of 2.28%. The ex-dividend date of this dividend is Tuesday, January 23rd. Clorox’s payout ratio is 61.88%.
In related news, SVP Michael R. Costello sold 10,574 shares of the firm’s stock in a transaction on Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total value of $1,438,169.74. Following the completion of the sale, the senior vice president now owns 34,867 shares of the company’s stock, valued at $4,742,260.67. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Matthew T. Laszlo sold 20,051 shares of the firm’s stock in a transaction on Wednesday, November 8th. The stock was sold at an average price of $130.46, for a total value of $2,615,853.46. Following the completion of the sale, the senior vice president now directly owns 10,896 shares of the company’s stock, valued at approximately $1,421,492.16. The disclosure for this sale can be found here. Company insiders own 1.00% of the company’s stock.
Hedge funds have recently made changes to their positions in the stock. Parametric Portfolio Associates LLC lifted its position in Clorox by 3.9% during the third quarter. Parametric Portfolio Associates LLC now owns 536,640 shares of the company’s stock valued at $70,788,000 after buying an additional 20,303 shares during the period. Steward Partners Investment Advisory LLC purchased a new position in Clorox during the third quarter valued at $561,000. Smith Shellnut Wilson LLC ADV lifted its position in Clorox by 82.3% during the third quarter. Smith Shellnut Wilson LLC ADV now owns 4,042 shares of the company’s stock valued at $533,000 after buying an additional 1,825 shares during the period. Archford Capital Strategies LLC lifted its position in Clorox by 14.0% during the third quarter. Archford Capital Strategies LLC now owns 8,121 shares of the company’s stock valued at $1,071,000 after buying an additional 997 shares during the period. Finally, Moors & Cabot Inc. lifted its position in Clorox by 35.2% during the third quarter. Moors & Cabot Inc. now owns 3,456 shares of the company’s stock valued at $452,000 after buying an additional 899 shares during the period. 73.42% of the stock is owned by institutional investors.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.